Copyright Reports & Markets. All rights reserved.

Global Age-related Macular Degeneration Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Age-related Macular Degeneration Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Age-related Macular Degeneration Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Wet AMD
    • 1.4.3 Dry AMD
  • 1.5 Market by Application
    • 1.5.1 Global Age-related Macular Degeneration Market Share by Application: 2020 VS 2026
    • 1.5.2 Drugstore
    • 1.5.3 Hospital
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Age-related Macular Degeneration Market Perspective (2015-2026)
  • 2.2 Global Age-related Macular Degeneration Growth Trends by Regions
    • 2.2.1 Age-related Macular Degeneration Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Age-related Macular Degeneration Historic Market Share by Regions (2015-2020)
    • 2.2.3 Age-related Macular Degeneration Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Age-related Macular Degeneration Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Age-related Macular Degeneration Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Age-related Macular Degeneration Players by Market Size
    • 3.1.1 Global Top Age-related Macular Degeneration Players by Revenue (2015-2020)
    • 3.1.2 Global Age-related Macular Degeneration Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Age-related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Age-related Macular Degeneration Market Concentration Ratio
    • 3.2.1 Global Age-related Macular Degeneration Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Age-related Macular Degeneration Revenue in 2019
  • 3.3 Age-related Macular Degeneration Key Players Head office and Area Served
  • 3.4 Key Players Age-related Macular Degeneration Product Solution and Service
  • 3.5 Date of Enter into Age-related Macular Degeneration Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Age-related Macular Degeneration Historic Market Size by Type (2015-2020)
  • 4.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Age-related Macular Degeneration Market Size by Application (2015-2020)
  • 5.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Age-related Macular Degeneration Market Size (2015-2020)
  • 6.2 Age-related Macular Degeneration Key Players in North America (2019-2020)
  • 6.3 North America Age-related Macular Degeneration Market Size by Type (2015-2020)
  • 6.4 North America Age-related Macular Degeneration Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Age-related Macular Degeneration Market Size (2015-2020)
  • 7.2 Age-related Macular Degeneration Key Players in Europe (2019-2020)
  • 7.3 Europe Age-related Macular Degeneration Market Size by Type (2015-2020)
  • 7.4 Europe Age-related Macular Degeneration Market Size by Application (2015-2020)

8 China

  • 8.1 China Age-related Macular Degeneration Market Size (2015-2020)
  • 8.2 Age-related Macular Degeneration Key Players in China (2019-2020)
  • 8.3 China Age-related Macular Degeneration Market Size by Type (2015-2020)
  • 8.4 China Age-related Macular Degeneration Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Age-related Macular Degeneration Market Size (2015-2020)
  • 9.2 Age-related Macular Degeneration Key Players in Japan (2019-2020)
  • 9.3 Japan Age-related Macular Degeneration Market Size by Type (2015-2020)
  • 9.4 Japan Age-related Macular Degeneration Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Age-related Macular Degeneration Market Size (2015-2020)
  • 10.2 Age-related Macular Degeneration Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Age-related Macular Degeneration Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Age-related Macular Degeneration Market Size by Application (2015-2020)

11 India

  • 11.1 India Age-related Macular Degeneration Market Size (2015-2020)
  • 11.2 Age-related Macular Degeneration Key Players in India (2019-2020)
  • 11.3 India Age-related Macular Degeneration Market Size by Type (2015-2020)
  • 11.4 India Age-related Macular Degeneration Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Age-related Macular Degeneration Market Size (2015-2020)
  • 12.2 Age-related Macular Degeneration Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Age-related Macular Degeneration Market Size by Type (2015-2020)
  • 12.4 Central & South America Age-related Macular Degeneration Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Bayer HealthCare
    • 13.1.1 Bayer HealthCare Company Details
    • 13.1.2 Bayer HealthCare Business Overview
    • 13.1.3 Bayer HealthCare Age-related Macular Degeneration Introduction
    • 13.1.4 Bayer HealthCare Revenue in Age-related Macular Degeneration Business (2015-2020))
    • 13.1.5 Bayer HealthCare Recent Development
  • 13.2 F. Hoffmann-La Roche
    • 13.2.1 F. Hoffmann-La Roche Company Details
    • 13.2.2 F. Hoffmann-La Roche Business Overview
    • 13.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Introduction
    • 13.2.4 F. Hoffmann-La Roche Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.2.5 F. Hoffmann-La Roche Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview
    • 13.3.3 Novartis Age-related Macular Degeneration Introduction
    • 13.3.4 Novartis Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 Regeneron Pharmaceuticals
    • 13.4.1 Regeneron Pharmaceuticals Company Details
    • 13.4.2 Regeneron Pharmaceuticals Business Overview
    • 13.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Introduction
    • 13.4.4 Regeneron Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.4.5 Regeneron Pharmaceuticals Recent Development
  • 13.5 Alcon
    • 13.5.1 Alcon Company Details
    • 13.5.2 Alcon Business Overview
    • 13.5.3 Alcon Age-related Macular Degeneration Introduction
    • 13.5.4 Alcon Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.5.5 Alcon Recent Development
  • 13.6 Allergan
    • 13.6.1 Allergan Company Details
    • 13.6.2 Allergan Business Overview
    • 13.6.3 Allergan Age-related Macular Degeneration Introduction
    • 13.6.4 Allergan Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.6.5 Allergan Recent Development
  • 13.7 Avalanche
    • 13.7.1 Avalanche Company Details
    • 13.7.2 Avalanche Business Overview
    • 13.7.3 Avalanche Age-related Macular Degeneration Introduction
    • 13.7.4 Avalanche Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.7.5 Avalanche Recent Development
  • 13.8 Bausch+Lomb
    • 13.8.1 Bausch+Lomb Company Details
    • 13.8.2 Bausch+Lomb Business Overview
    • 13.8.3 Bausch+Lomb Age-related Macular Degeneration Introduction
    • 13.8.4 Bausch+Lomb Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.8.5 Bausch+Lomb Recent Development
  • 13.9 Gilead Sciences
    • 13.9.1 Gilead Sciences Company Details
    • 13.9.2 Gilead Sciences Business Overview
    • 13.9.3 Gilead Sciences Age-related Macular Degeneration Introduction
    • 13.9.4 Gilead Sciences Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.9.5 Gilead Sciences Recent Development
  • 13.10 Iconic Therapeutics
    • 13.10.1 Iconic Therapeutics Company Details
    • 13.10.2 Iconic Therapeutics Business Overview
    • 13.10.3 Iconic Therapeutics Age-related Macular Degeneration Introduction
    • 13.10.4 Iconic Therapeutics Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 13.10.5 Iconic Therapeutics Recent Development
  • 13.11 Neurotech Pharmaceuticals
    • 10.11.1 Neurotech Pharmaceuticals Company Details
    • 10.11.2 Neurotech Pharmaceuticals Business Overview
    • 10.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Introduction
    • 10.11.4 Neurotech Pharmaceuticals Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 10.11.5 Neurotech Pharmaceuticals Recent Development
  • 13.12 Ohr Pharmaceutical
    • 10.12.1 Ohr Pharmaceutical Company Details
    • 10.12.2 Ohr Pharmaceutical Business Overview
    • 10.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Introduction
    • 10.12.4 Ohr Pharmaceutical Revenue in Age-related Macular Degeneration Business (2015-2020)
    • 10.12.5 Ohr Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Age-related Macular Degeneration market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Age-related Macular Degeneration market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Bayer HealthCare
    F. Hoffmann-La Roche
    Novartis
    Regeneron Pharmaceuticals
    Alcon
    Allergan
    Avalanche
    Bausch+Lomb
    Gilead Sciences
    Iconic Therapeutics
    Neurotech Pharmaceuticals
    Ohr Pharmaceutical

    Market segment by Type, the product can be split into
    Wet AMD
    Dry AMD
    Market segment by Application, split into
    Drugstore
    Hospital
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now